FDA Inspection
Centaur Pharmaceuticals Private Ltd.Centaur Pharmaceuticals Private Ltd. – FDA Inspection, Nov 21, 2022
Record Details
This FDA Inspection record concerns Centaur Pharmaceuticals Private Ltd., with an inspection on November 21, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- November 21, 2022
- Product Type
- Drugs
View Company Profile
ID · a0c00f2b-71be-424c-b952-304a0e76ebce
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1192256
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Centaur Pharmaceuticals Private Ltd.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| July 25, 2025 | Not classified | Office of Inspections and Investigations | |
| September 27, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 13, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 5, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 11, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Centaur Pharmaceuticals Private Ltd.
- FDA Inspection 1281041 - 2025-07-25
- FDA Inspection 1107995 - 2019-09-27
- FDA Inspection 994501 - 2016-10-13
- FDA Inspection 914387 - 2015-02-05
- FDA Inspection 740701 - 2011-08-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.